clandestine laboratories
Recently Published Documents


TOTAL DOCUMENTS

21
(FIVE YEARS 4)

H-INDEX

4
(FIVE YEARS 1)

2021 ◽  
Vol 11 (9) ◽  
pp. 3754
Author(s):  
René Reiss ◽  
Frank Hauser ◽  
Sven Ehlert ◽  
Michael Pütz ◽  
Ralf Zimmermann

While fast and reliable analytical results are crucial for first responders to make adequate decisions, these can be difficult to establish, especially at large-scale clandestine laboratories. To overcome this issue, multiple techniques at different levels of complexity are available. In addition to the level of complexity their information value differs as well. Within this publication, a comparison between three techniques that can be applied for on-site analysis is performed. These techniques range from ones with a simple yes or no response to sophisticated ones that allows to receive complex information about a sample. The three evaluated techniques are immunoassay drug tests representing easy to handle and fast to explain systems, ion mobility spectrometry as state-of-the-art equipment that needs training and experience prior to use and ambient pressure laser desorption with the need for a highly skilled operator as possible future technique that is currently under development. In addition to the measurement of validation parameters, real case samples are investigated to obtain practically relevant information about the capabilities and limitations of these techniques for on-site operations. Results demonstrate that in general all techniques deliver valid results, but the bandwidth of information widely varies between the investigated techniques.


2020 ◽  
Vol 11 ◽  
pp. 49-52
Author(s):  
Robert E. Adamyan ◽  

The aim of the study was a comprehensive analysis of theoretical, organizational and legal problems arising in the process of operational-search support for the disclosure and investigation of crimes related to drug production in clandestine laboratories. Based on the results of the study, the author (based on the analysis of materials from practical activities) identified the features of the operational- search support for solving crimes related to the production of drugs in clandestine laboratories, and suggested ways of solving them.


2020 ◽  
Vol 64 (4) ◽  
Author(s):  
Déborah Delaune ◽  
Frédéric Iseni

ABSTRACT Forty years after the last endemic smallpox case, variola virus (VARV) is still considered a major threat to humans due to its possible use as a bioterrorism agent. For many years, the risk of disease reemergence was thought to solely be through deliberate misuse of VARV strains kept in clandestine laboratories. However, recent experiments using synthetic biology have proven the feasibility of recreating a poxvirus de novo, implying that VARV could, in theory, be resurrected. Because of this new perspective, the WHO Advisory Committee on VARV Research released new recommendations concerning research on poxviruses that strongly encourages pursuing the development of new antiviral drugs against orthopoxviruses. In 2018, the U.S. FDA advised in favor of two molecules for smallpox treatment, tecovirimat and brincidofovir. This review highlights the difficulties to develop new drugs targeting an eradicated disease, especially as it requires working under the FDA “animal efficacy rule” with the few, and imperfect, animal models available.


Sign in / Sign up

Export Citation Format

Share Document